World's Best Scientists 2026 revealed!
Francesco Rodeghiero

Francesco Rodeghiero

D-Index & Metrics

Medicine

D-Index
95
Citations
45601
World Ranking
9896
National Ranking
275

Francesco Rodeghiero publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Francesco Rodeghiero sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 539 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Francesco Rodeghiero D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Francesco Rodeghiero sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Francesco Rodeghiero is affiliated with Yamagata University in Japan and has contributed to the field of medicine, with particular focus on hematology and related subfields. Their research encompasses a range of topics including myeloproliferative neoplasms, platelet disorders, eosinophilic syndromes, and antiplatelet therapy.

They have authored publications covering diverse aspects of blood disorders, often examining clinical treatments and disease progression. Notable recent papers include:

  • A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia, 2020, Blood
  • Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial, 2024, American Journal of Hematology
  • The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients, 2023, Blood Cancer Journal
  • Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia, 2021, Clinical Pharmacology & Therapeutics
  • Splenectomy: still a life-saving treatment in immune thrombocytopenia, 2025, Haematologica

Their frequent coauthors include Marco Ruggeri, Maria Luigia Randi, Irene Bertozzi, Alessandro M. Vannucchi, and Bianca Rocca, illustrating collaboration within the hematology research community.

Publications by Francesco Rodeghiero have appeared in venues such as Blood, American Journal of Hematology, Blood Cancer Journal, Clinical Pharmacology & Therapeutics, and Haematologica, reflecting a focus on hematological research.

Main fields of study linked to their research include Medicine, with subfields centering on hematology, genetics, rheumatology, cardiology and cardiovascular medicine, as well as molecular biology.

Their core research topics cover:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Platelet Disorders and Treatments
  • Eosinophilic Disorders and Syndromes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Kruppel-like factors research
  • Blood groups and transfusion
  • Renal Diseases and Glomerulopathies

Best Publications

  • Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

    Francesco Rodeghiero;Roberto Stasi;Terry Gernsheimer;Marc Michel

  • International consensus report on the investigation and management of primary immune thrombocytopenia.

    Drew Provan;Roberto Stasi;Adrian C. Newland;Victor S. Blanchette

  • Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

    J Danesh;S Lewington;S G Thompson;Lowe Gdo.

  • Epidemiological Investigation of the Prevalence of von Willebrand's Disease

    Francesco Rodeghiero;Giancarlo Castaman;Enrico Dini

  • Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

    J E Sadler;U Budde;J C J Eikenboom;E J Favaloro

  • Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis

    Sergio Cortelazzo;Guido Finazzi;Marco Ruggeri;Oscar Vestri

  • Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

    Miguel A. Sanz;Francesco Lo Coco;Guillermo Martı́n;Giuseppe Avvisati

  • Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study

    A Tefferi;E Rumi;G Finazzi;H Gisslinger

  • Molecular Remission in PML/RARα-Positive Acute Promyelocytic Leukemia by Combined All-trans Retinoic Acid and Idarubicin (AIDA) Therapy

    Franco Mandelli;Daniela Diverio;Giuseppe Avvisati;Anna Luciano

  • Impact, Diagnosis and Treatment of von Willebrand Disease*

    J E Sadler;P M Mannucci;Erik Berntorp;N Bochkov

  • Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

    Tiziano Barbui;Guido Finazzi;Alessandra Carobbio;Juergen Thiele

  • Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.

    Sergio Cortelazzo;Piera Viero;Guido Finazzi;Anna D'Emilio

  • A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)

    A Tosetto;F Rodeghiero;G Castaman;A Goodeve

  • Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

    Tiziano Barbui;Juergen Thiele;Francesco Passamonti;Elisa Rumi

  • Phenotype and genotype of a cohort of families historically diagnosed with Type 1 von Willebrand Disease in the European study, molecular and clinical markers for the diagnosis and management of Type 1 von Willebrand Disease (MCMDM-1VWD)

    Anne C. Goodeve;Jeroen Eikenboom;Giancarlo Castaman;Francesco Rodeghiero

  • Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.

    Alessandra Carobbio;Juergen Thiele;Francesco Passamonti;Elisa Rumi

  • Prognostic impact of c-KIT mutations in core binding factor leukemias. an Italian retrospective study

    Roberto Cairoli;Alessandro Beghini;Giovanni Grillo;Gianpaolo Nadali

  • Romiplostim or standard of care in patients with immune thrombocytopenia.

    David J. Kuter;Mathias Rummel;Ralph Boccia;B. Gail Macik

  • The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.

    F Rodeghiero;G Castaman;A Tosetto;J Batlle

  • Acquired von Willebrand syndrome: data from an international registry.

    A. B. Federici;J. H. Rand;P. Bucciarelli;U. Budde

Frequent Co-Authors

Tiziano Barbui
Tiziano Barbui FROM-Fondazione per la Ricerca Ospedale di Bergamo
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Guido Finazzi
Guido Finazzi Mario Negri Institute for Pharmacological Research
Pier Mannuccio Mannucci
Pier Mannuccio Mannucci Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Giovanni Pizzolo
Giovanni Pizzolo University of Verona
Francesco Passamonti
Francesco Passamonti University of Milan
Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Wilma Barcellini
Wilma Barcellini Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Ingrid Pabinger
Ingrid Pabinger Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA can be complemented by a variety of related online degrees and flexible career pathways. For Registered Nurses looking to advance skills and move into practitioner roles, the rn to np bridge program offers an accelerated route to become a nurse practitioner. This pathway is ideal for nurses seeking more autonomy and responsibility in patient care.

For those interested in nutrition and wellness, earning a nutritionist online degree opens doors in healthcare, sports, and community settings. These degrees are especially relevant as dietary guidance plays an increasing role in preventive medicine.

Leadership roles in health services are another growing area—an option is pursuing cahme accredited online healthcare administration programs. These provide training for management and policy positions in hospitals, clinics, or public health organizations.

Lastly, if you are a nurse aiming to boost credentials quickly, online rn to bsn programs no clinicals offer a streamlined learning experience without traditional in-person requirements.

Best Scientists Citing Francesco Rodeghiero

Trending Scientists

Recently Published Articles